Moderna secures fill-finish capabilities for COVID-19 vaccine 29-Jun-2020 By Ben Hargreaves Moderna signs deal with Catalent for fill-finish services, shortly after AZ announced the same move.
WHO seeks $31bn in next 18 months to combat COVID-19 29-Jun-2020 By Ben Hargreaves The organization wants to raise the sum to support its ‘three pillar’ approach to the pandemic: vaccines, therapeutics, and diagnostics.
Cytiva expands Massachusetts biomanufacturing site 25-Jun-2020 By Ben Hargreaves The facility has been expanded to cater to the growing number of small- to mid-size biotechs looking to contract manufacture.
AstraZeneca makes another vaccine supply agreement 25-Jun-2020 By Ben Hargreaves AZ enters a supply agreement with Symbiosis as it continues to work on bolstering supply for its COVID-19 vaccine.
Hired & Retired: From big pharma to mid-sized leadership 24-Jun-2020 By Ben Hargreaves This month featured executives making the switch from big pharma to take on leadership positions at mid-sized companies.
Gilead continues small deal spree 23-Jun-2020 By Ben Hargreaves Gilead buys a stake in Pionyr and holds the option to acquire the biotech outright.
Sanofi ties up $2.3bn Translate Bio agreement 23-Jun-2020 By Ben Hargreaves The partners extend an existing collaboration to develop mRNA vaccines against infectious diseases.
Biotech launches with $300m and ‘high precision’ cell therapies 23-Jun-2020 By Ben Hargreaves Orca Bio emerges with a manufacturing platform that it claims produces cell therapies with an ‘unprecedented turnaround time’.
Europe working to secure supply of J&J vaccine 22-Jun-2020 By Ben Hargreaves European Commission is working to guarantee access to J&J’s vaccine, as it bulks up vaccine supply, reports suggest.
Novo Nordisk provides €100m for sustainable cell factories 22-Jun-2020 By Ben Hargreaves Novo Nordisk Foundation donates funds to DTU Biosustain to continue its work to develop methods for sustainable biotechnologies.
Emergent in $75m expansion into viral vectors and gene therapy 22-Jun-2020 By Ben Hargreaves The company will buildout its Massachusetts facility to provide CDMO services for viral vector and gene therapies.
Sanofi to invest €610m in vaccine production site 18-Jun-2020 By Ben Hargreaves The company will create both a vaccine site and an R&D center in France.
Catalent to fill and package AZ’s COVID-19 vaccine 18-Jun-2020 By Ben Hargreaves The CDMO seals a deal to provide vial filling and packaging services for the commercialization of AZ’s potential COVID-19 vaccine.
Gavi backed with $8.8bn to support immunization plans 17-Jun-2020 By Ben Hargreaves The Vaccine Alliance given funds to support the immunization of 300 million children and to develop measures against COVID-19.
TreeFrog opens stem cell manufacturing facility 16-Jun-2020 By Ben Hargreaves The startup completes work on facility to produce stem cell therapies in-house.
